{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T04:41:52Z","timestamp":1768797712331,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.pbb.2010.07.021","type":"journal-article","created":{"date-parts":[[2010,8,15]],"date-time":"2010-08-15T04:41:38Z","timestamp":1281847298000},"page":"179-184","source":"Crossref","is-referenced-by-count":58,"title":["The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior"],"prefix":"10.1016","volume":"97","author":[{"given":"P.A.","family":"Randall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.K.","family":"Vemuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.N.","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Ferreris","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hosmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.J.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Santerre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Makriyannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Salamone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2010.07.021_bb0005","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/0091270008317591","article-title":"Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers","volume":"48","author":"Addy","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pbb.2010.07.021_bb0010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s002130050326","article-title":"Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors","volume":"132","author":"Arnone","year":"1997","journal-title":"Psychopharmacology"},{"issue":"Suppl","key":"10.1016\/j.pbb.2010.07.021_bb0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0195-6663(86)80051-4","article-title":"Serotonin manipulations and the structure of feeding behaviour","volume":"7","author":"Blundell","year":"1986","journal-title":"Appetite"},{"key":"10.1016\/j.pbb.2010.07.021_bb0020","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0091-3057(80)90155-0","article-title":"Characterisation of adjustments to the structure of feeding behaviour following pharmacological treatment: effects of amphetamine and fenfluramine and the antagonism produced by pimozide and methergoline","volume":"12","author":"Blundell","year":"1980","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2010.07.021_bb0025","doi-asserted-by":"crossref","first-page":"R2185","DOI":"10.1152\/ajpregu.00663.2007","article-title":"A neutral CB1 receptor antagonist reduces weight gain in rat","volume":"293","author":"Chambers","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pbb.2010.07.021_bb0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1476-5381.2010.00908.x","article-title":"A novel, peripherally restricted, cannabinoid 1 (CB1) receptor antagonist AM6545 reduces food intake and body weight, but does not cause malaise, in rodents","volume":"161","author":"Cluny","year":"2010","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.pbb.2010.07.021_bb0035","doi-asserted-by":"crossref","first-page":"PL113","DOI":"10.1016\/S0024-3205(98)00322-1","article-title":"Appetite suppression and weight loss after the cannabinoid antagonist SR 141716","volume":"63","author":"Colombo","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2010.07.021_bb0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2004.07.009","article-title":"Endocannabinoids and food consumption: comparisons with benzodiazepine and opioid palatability-dependent appetite","volume":"500","author":"Cooper","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2010.07.021_bb0045","first-page":"CD006162","article-title":"Rimonabant for overweight or obesity","volume":"4","author":"Curioni","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pbb.2010.07.021_bb0050","doi-asserted-by":"crossref","unstructured":"Despres JP, Golay A, Sjostrom L. Rimonabant in Obesity-Lipids Study Group, 2005. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 2006; 353: 2121\u20132134.","DOI":"10.1056\/NEJMoa044537"},{"key":"10.1016\/j.pbb.2010.07.021_bb0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0091-3057(00)00359-2","article-title":"Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding","volume":"67","author":"Freedland","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2010.07.021_bb0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2005.11.032","article-title":"Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor \u2018silent antagonist\u2019","volume":"530","author":"Gardner","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2010.07.021_bb0065","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1523\/JNEUROSCI.22-21-09612.2002","article-title":"A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding","volume":"22","author":"Gomez","year":"2002","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.pbb.2010.07.021_bb0070","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00213-002-1263-3","article-title":"Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716","volume":"165","author":"Higgs","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2010.07.021_bb0075","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbr.2008.06.010","article-title":"The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats","volume":"193","author":"Hodge","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2010.07.021_bb0080","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/sj.bjp.0704379","article-title":"Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats","volume":"134","author":"Jamshidi","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2010.07.021_bb0085","series-title":"Design and analysis: a researchers handbook","author":"Keppel","year":"1982"},{"key":"10.1016\/j.pbb.2010.07.021_bb0090","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","article-title":"Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol","volume":"136","author":"Kirkham","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2010.07.021_bb0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00213-009-1506-7","article-title":"The future of endocannabinoid-oriented clinical research after CB1 antagonists","volume":"205","author":"Le Foll","year":"2009","journal-title":"Psychopharm (Berl)"},{"key":"10.1016\/j.pbb.2010.07.021_bb0100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00008877-200312000-00002","article-title":"The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats","volume":"14","author":"McLaughlin","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2010.07.021_bb0105","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00213-005-2171-0","article-title":"The cannabinoid CB1 antagonist AM251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats","volume":"180","author":"McLaughlin","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2010.07.021_bb0110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.pbb.2006.02.022","article-title":"Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist\/inverse agonist AM1387","volume":"83","author":"McLaughlin","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2010.07.021_bb0120","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.pbb.2010.07.021_bb0125","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00008877-200509000-00013","article-title":"Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-na\u00efve and plus-maze-experienced mice","volume":"16","author":"Rodgers","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2010.07.021_bb0215","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0306-4522(90)90218-S","article-title":"Characterization of the impaired feeding behavior in rats given haloperidol or dopamine-depleting brain lesions","volume":"39","author":"Salamone","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2010.07.021_bb0130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0091-3057(93)90174-R","article-title":"Ventrolateral striatal dopamine depletions impair feeding and food handling in rats","volume":"44","author":"Salamone","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2010.07.021_bb0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.physbeh.2007.04.013","article-title":"Cannabinoid CB(1) receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions","volume":"91","author":"Salamone","year":"2007","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pbb.2010.07.021_bb0140","first-page":"179","article-title":"SR141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset","volume":"9","author":"Simiand","year":"1998","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2010.07.021_bb0145","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/sj.npp.1301476","article-title":"The novel cannabinoid CB(1) receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats","volume":"43","author":"Sink","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2010.07.021_bb0150","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00213-007-0988-4","article-title":"Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior","volume":"196","author":"Sink","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2010.07.021_bb0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pbb.2008.07.013","article-title":"Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: effects on food-reinforced behavior and comparisons with AM4113","volume":"91","author":"Sink","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2010.07.021_bb0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-009-1602-8","article-title":"Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats","volume":"206","author":"Sink","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2010.07.021_bb0165","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.euroneuro.2009.11.002","article-title":"Potential anxiogenic effects of cannabinoid CB1 receptor antagonists\/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142","volume":"20","author":"Sink","year":"2010","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2010.07.021_bb0170","doi-asserted-by":"crossref","unstructured":"Sink KS, Segovia KN, Collins LE, Markus EJ, Vemuri VK, Makriyannis A, Salamone JD. The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats. Pharmacol Biochem Behav 2010:95:479\u201384.","DOI":"10.1016\/j.pbb.2010.03.011"},{"key":"10.1016\/j.pbb.2010.07.021_bb0175","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/FBP.0b013e3282eff0a9","article-title":"Acute anorectic response to cannabinoid CB1 receptor antagonist\/inverse agonist AM 251 in rats: indirect behavioural mediation","volume":"18","author":"Tallett","year":"2007","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2010.07.021_bb0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-007-0880-2","article-title":"Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats","volume":"195","author":"Tallett","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2010.07.021_bb0185","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00213-004-2047-8","article-title":"The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food","volume":"179","author":"Thornton-Jones","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2010.07.021_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-007-0745-8","article-title":"A comparison of the effects of the CB(1) receptor antagonist SR141716A, pre-feeding and changed palatability on the microstructure of ingestive behaviour","volume":"193","author":"Thornton-Jones","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2010.07.021_bb0195","unstructured":"US Food and Drug Administration Advisory Committee. FDA briefing document: zimulti (rimonabant) Tablets, 20mg, FDA, Rockville. [WWW document]. URL (http:\/\/www.fda.gov\/OHRMS\/DOCKETS\/AC\/07\/briefing\/2007-4306b1-00-index.htm). 2007."},{"key":"10.1016\/j.pbb.2010.07.021_bb0200","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2010.07.021_bb0205","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00008877-200509000-00010","article-title":"The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940)","volume":"16","author":"Ward","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2010.07.021_bb0210","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130050953","article-title":"Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors","volume":"143","author":"Williams","year":"1999","journal-title":"Psychopharmacology"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305710002339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305710002339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T18:53:18Z","timestamp":1559415198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305710002339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0091305710002339"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2010.07.021","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}